Does TENOFOVIR DISOPROXIL Cause Off label use? 310 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 310 reports of Off label use have been filed in association with TENOFOVIR DISOPROXIL (Tenofovir Disoproxil Fumarate). This represents 1.2% of all adverse event reports for TENOFOVIR DISOPROXIL.
310
Reports of Off label use with TENOFOVIR DISOPROXIL
1.2%
of all TENOFOVIR DISOPROXIL reports
44
Deaths
90
Hospitalizations
How Dangerous Is Off label use From TENOFOVIR DISOPROXIL?
Of the 310 reports, 44 (14.2%) resulted in death, 90 (29.0%) required hospitalization, and 5 (1.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENOFOVIR DISOPROXIL. However, 310 reports have been filed with the FAERS database.
What Other Side Effects Does TENOFOVIR DISOPROXIL Cause?
Bone density decreased (10,586)
Renal injury (9,255)
Skeletal injury (8,320)
Chronic kidney disease (7,230)
Osteonecrosis (7,182)
Bone loss (7,040)
Multiple fractures (6,793)
Renal failure (6,388)
Osteoporosis (5,302)
Tooth loss (4,483)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TENOFOVIR DISOPROXIL Alternatives Have Lower Off label use Risk?
TENOFOVIR DISOPROXIL vs TEPLIZUMAB-MZWV
TENOFOVIR DISOPROXIL vs TEPOTINIB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB-TRBW
TENOFOVIR DISOPROXIL vs TERAZOSIN